Disclosures for "Early Experience on Omaveloxolone in Adult Patients with Friedreich’s Ataxia: A Real-world Observational Study"
-
Dr. Lima has nothing to disclose.
-
Miss Caltagirone has nothing to disclose.
-
Dr. Messina has nothing to disclose.
-
Dr. Rini has nothing to disclose.
-
Dr. Quartetti has nothing to disclose.
-
Dr. DAmico has nothing to disclose.
-
Dr. Alonge has nothing to disclose.
-
Prof. Brighina has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Prof. Brighina has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. Prof. Brighina has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lilly. Prof. Brighina has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alnylam Pharmaceuticals.
-
Dr. Di Stefano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen.